AnalystsRichard LawRichard Law's Stock Forecasts
AnalystsRichard Law
Sectors:
Industries:
Analyst Ranking
Top 21%
#1025 out of 5087 analysts
Average Return
+8.93%
Win Rate
37%13 out of 35
Risk vs Reward
Poor
Good
Richard Law's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Mineralys Therapeutics IncMLYS | +300.59% | $10.20 | $40.86 | 2025-02-12 - 2025-10-31 | Strong Buy |
Olema Pharmaceuticals IncOLMA | +234.19% | $3.89 | $13.00 | 2023-03-09 - 2024-03-08 | Buy |
Olema Pharmaceuticals IncOLMA | +204.17% | $4.56 | $13.87 | 2023-02-21 - 2024-02-21 | Buy |
Merus NvMRUS | +113.87% | $44.36 | $94.86 | 2024-11-20 - 2025-10-31 | Strong Buy |
Olema Pharmaceuticals IncOLMA | +99.33% | $4.50 | $8.97 | 2025-05-13 - 2025-10-31 | Strong Buy |
Richard Law Analyst Color
Get additional color on Richard Law's coverage of popular stocks
Richard Law's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Arcutis Biotherapeutics IncARQT | 2 | Hold | $29.00 | +14.58% | Maintains | 2 days ago |
Crinetics Pharmaceuticals IncCRNX | 1 | Hold | $40.00 | -8.05% | Maintains | a month ago |
Mineralys Therapeutics IncMLYS | 7 | Strong Buy | $52.00 | +27.26% | Maintains | 2 months ago |
Viridian Therapeutics IncVRDN | 4 | Strong Buy | $30.00 | +26.96% | Maintains | 3 months ago |
Moonlake ImmunotherapeuticsMLTX | 4 | Strong Buy | $82.00 | +711.88% | Maintains | 3 months ago |
Olema Pharmaceuticals IncOLMA | 5 | Strong Buy | $18.00 | +100.67% | Maintains | 6 months ago |
Silence Therapeutics PLCSLN | 3 | Strong Sell | $3.00 | -58.10% | Maintains | 6 months ago |
Rocket Pharmaceuticals IncRCKT | 3 | Hold | $13.00 | +244.83% | Maintains | 6 months ago |
Celldex Therapeutics IncCLDX | 3 | Hold | $31.00 | +15.97% | Maintains | 6 months ago |
Viking Therapeutics IncVKTX | 1 | Hold | $30.00 | -21.22% | Initiates Coverage On | 7 months ago |
Merus NvMRUS | 1 | Strong Buy | $73.00 | -23.04% | Initiates Coverage On | a year ago |
Monte Rosa Therapeutics IncGLUE | 4 | Hold | $11.00 | N/A | Reiterates | 2 years ago |
Verve Therapeutics IncVERV | 2 | Hold | $31.00 | N/A | Reiterates | 2 years ago |
Beam Therapeutics IncBEAM | 3 | Hold | $47.00 | N/A | Maintains | 2 years ago |
Crispr Therapeutics AgCRSP | 6 | Hold | $63.00 | N/A | Maintains | 2 years ago |
Kymera Therapeutics IncKYMR | 8 | Hold | $37.00 | N/A | Maintains | 2 years ago |
Intellia Therapeutics IncNTLA | 5 | Buy | $76.00 | N/A | Reiterates | 2 years ago |
Q32 Bio IncQTTB | 4 | Hold | $36.00 | N/A | Reiterates | 2 years ago |
Editas Medicine IncEDIT | 3 | Hold | $14.00 | N/A | Maintains | 2 years ago |
Arvinas IncARVN | 4 | Buy | $61.00 | N/A | Reiterates | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.